Ranipedia Syrup

Ranitidine competitively inhibits the binding of histamine to receptors on gastric parietal cells (designated as the H2-receptor), thus reducing basal and nocturnal gastric acid secretion. The drug also decreases the amount of gastric acid released in response to stimuli such as food, betazole, or pentagastrin. Ranitidine reduces the total volume of gastric juice, thereby indirectly decreasing pepsin secretion.

Indications:

• Gastroesophageal Reflux Disease (GERD) (Short-term treatment)
• Erosive Esophagitis
• Peptic Ulcer Disease (Duodenal Ulcer or Gastric Ulcer)
• Gastritis

Dosage & Administration:

• Gastroesophageal Reflux Disease (GERD) (Short–term treatment): 5 to 10 mg/kg/day orally divided 2 to 3 times per day (Max: 300 mg/day)
• Erosive Esophagitis: 5 to 10 mg/kg/day orally divided 2 to 3 times per day (Max: 600 mg/day).
• Peptic Ulcer Disease (Duodenal Ulcer or Gastric Ulcer) & Gastritis: 2 to 4 mg/kg/dose orally twice daily (Max: 300 mg/day).

HOW SUPPLIED: RANIPEDIA SYRUP is available as syrup in 100 ml pack